PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.65%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-29.90%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-11.75%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
5.88%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
6.16%
R&D change of 6.16% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
2.68%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-9.25%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
-140.00%
Other expenses reduction while CRWV shows 19.33% growth. Joel Greenblatt would examine efficiency.
-2.37%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-14.41%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.98%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-19.84%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-2.06%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-20.27%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-4.33%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-104.49%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-22.77%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-7.34%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-22.29%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-22.89%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-7.48%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-22.78%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-23.08%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.01%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
0.39%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.